Market Outlook

By 2035, the U.S. Minimally Invasive Surgery Operating Room Equipment Market is expected to reach approximately USD 29.51 billion, expanding at a CAGR of 9.60% during the forecast period 2026–2035. The market is estimated at USD 11.80 billion in 2025, with historical analysis covering 2021 through 2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 8.10 billion in 2021 to USD 10.64 billion in 2024, before reaching USD 11.80 billion in 2025. Recovery of elective surgical volumes, hospital capital-budget normalization, accelerating robotic-assisted surgery utilization, replacement of aging visualization platforms, increasing adoption of integrated operating rooms, and continued migration of appropriate procedures to outpatient settings supported this expansion.

The market covered in this report includes the operating-room equipment and capital technology infrastructure directly required to perform or enable minimally invasive surgical procedures. Major revenue pools include surgical visualization and endoscopy systems, robotic-assisted surgery systems, electrosurgical and advanced energy equipment, insufflation and smoke-management systems, surgical imaging and navigation platforms, integrated OR technologies, displays, recording and workflow-control systems, and associated reusable or system-linked procedural equipment. The scope excludes unrelated conventional OR capital equipment and avoids counting the entire disposable surgical-device market.

Demand is being shaped by a fundamental change in U.S. surgical economics. Minimally invasive surgery is no longer viewed primarily as an alternative operative technique. For many general surgery, urology, gynecology, colorectal, thoracic, bariatric, orthopedic, spine and selected cardiac procedures, it has become the preferred clinical pathway when anatomy, patient condition and surgeon capability permit.

The installed care infrastructure supporting this market is substantial. The U.S. hospital system contains roughly 6,100 hospitals, more than 907,000 staffed beds and approximately 35.7 million annual admissions. Meanwhile, the nationwide ambulatory surgery environment continues to expand; federal ambulatory-surgery data estimated approximately 13.5 million in-scope encounters in hospital-owned facilities in 2023.

Capital procurement is therefore shifting from isolated equipment purchasing toward procedure-platform investment. Hospitals increasingly assess whether an MIS platform can increase cases per room, reduce setup and turnover time, support multiple specialties, lower conversion-to-open risk, minimize equipment footprint, improve visualization, simplify staff training and connect intraoperative data with broader digital infrastructure. These requirements favor vendors capable of building interoperable surgical ecosystems rather than selling individual devices.

The strongest value expansion through 2035 is expected in robotic-assisted surgery, 4K and fluorescence visualization, AI-supported intraoperative imaging, integrated OR workflow, digital surgical analytics, smoke evacuation, advanced energy systems and navigation technologies. At the same time, conventional laparoscopy will remain a critical revenue base because it offers favorable procedure economics and remains the practical standard for a very large number of routine minimally invasive procedures.

 

Introduction

According to the U.S. Minimally Invasive Surgery Operating Room Equipment Market analysis, the industry sits at the intersection of surgical technology, hospital infrastructure, operating-room productivity and outpatient care migration. Its growth cannot be explained by procedure volume alone. The economic value of the market is increasingly determined by how effectively equipment enables hospitals to perform more complex surgery through smaller incisions while controlling labor requirements, room utilization, patient recovery time and total episode cost.

Minimally invasive surgery has already changed the composition of U.S. surgical care. Historical national analyses demonstrated that laparoscopic and thoracoscopic procedures represented a meaningful portion of both inpatient and ambulatory surgery, with MIS accounting for approximately 18% of ambulatory operating-room encounters by 2018. In hospital-owned ambulatory settings, approximately 11.9 million major surgical encounters occurred in 2019, illustrating the scale of the addressable outpatient surgical infrastructure even before subsequent expansion.

The economic logic behind MIS adoption is particularly important for U.S. providers. Lower-acuity minimally invasive procedures can reduce inpatient resource utilization, enable earlier discharge and improve operating-room capacity utilization. For commercial payers and Medicare, procedures performed safely in outpatient settings may also produce lower total facility costs than equivalent inpatient episodes. For hospitals, however, the economics are more nuanced. High-cost technology must generate enough incremental procedures, surgeon retention, referral volume or operating efficiency to justify capital expenditure.

This dynamic explains why procurement committees increasingly evaluate utilization per installed system. A hospital purchasing a robotic platform, high-definition visualization stack or integrated OR does not merely evaluate acquisition price. Executives assess annual case capacity, expected procedure mix, capital depreciation, disposable and service revenue implications, training requirements, room modification expenses, maintenance contracts, reimbursement exposure and the ability to standardize technology across an integrated delivery network.

Robotic surgery is creating one of the most consequential capital replacement cycles in the sector. During 2025, approximately 987 da Vinci systems were placed in the United States, while U.S. da Vinci procedure volume increased approximately 15%. Globally, Intuitive ended 2025 with roughly 11,106 installed da Vinci systems, illustrating both the maturity of robotic surgery and the remaining opportunity for replacement, capacity expansion and competitive platform entry.

Outpatient migration provides a second structural growth engine. The United States now has more than 6,500 Medicare-certified ambulatory surgery centers, creating a large customer base for compact surgical visualization, arthroscopy, endoscopy, energy systems, insufflation equipment and increasingly selected robotic platforms. Facility density is especially high in California, Florida, Texas, Georgia, Maryland, New Jersey, Arizona and Pennsylvania.

From 2026 through 2035, equipment manufacturers will increasingly compete on four interconnected capabilities: procedural performance, workflow economics, digital integration and service reliability. The equipment that wins hospital capital budgets will be technology capable of improving clinical confidence while also increasing asset utilization.

 

Key Market Drivers: What Is Driving the U.S. Minimally Invasive Surgery Operating Room Equipment Market?

The first major driver is the continuing conversion of eligible open surgical procedures toward laparoscopic, robotic-assisted, endoscopic, arthroscopic and image-guided approaches. The clinical rationale differs across specialties, but shorter incisions, lower tissue disruption, accelerated recovery and reduced hospitalization create strong demand for technologies that allow surgeons to perform increasingly complex procedures minimally invasively.

The second driver is the expansion of robotic-assisted surgery. Robotics has moved beyond prostatectomy and hysterectomy into general surgery, hernia repair, colorectal surgery, cholecystectomy, bariatric surgery, thoracic procedures and other indications. U.S. robotic procedure growth remains strong, and the entry of additional systems is changing procurement from a largely single-platform market toward a competitive capital-equipment category. Greater competition is expected to stimulate replacement activity, alternative commercial models and expansion into hospitals that previously considered robotics economically inaccessible.

The third driver is the migration of surgical care toward outpatient settings. Medicare payment policies for 2026 affect approximately 4,000 hospitals and 6,000 ASCs, demonstrating the institutional scale of the outpatient reimbursement environment. Separately, MedPAC reported that approximately 6,400 ASCs treated 3.4 million fee-for-service Medicare beneficiaries during 2024, with FFS Medicare and beneficiary spending on ASC services reaching approximately USD 7.5 billion.

This shift influences equipment design. ASCs generally have less tolerance for oversized capital platforms, long room turnover, extensive sterilization complexity and high fixed service costs. Vendors are responding with smaller footprints, modular towers, standardized accessories, faster setup, mobile equipment, reusable-disposable optimization and financing structures tied more closely to procedure volume.

The fourth driver is visualization modernization. Traditional HD systems are being replaced by 4K, high-dynamic-range, fluorescence-capable and digitally enhanced imaging platforms. Better visualization is particularly valuable when surgeons work through narrow access points because the camera effectively becomes the surgeon’s eye. Fluorescence imaging adds another layer by helping visualize perfusion, blood flow, ducts, vessels and selected tissue characteristics. This increases the strategic importance of cameras, light sources, processors, monitors, scopes and imaging agents as an integrated ecosystem.

The fifth driver is operating-room throughput. Labor constraints and rising hospital costs have made procedure duration, turnover time and equipment setup economically important. Technologies that eliminate redundant towers, simplify device connectivity, automate configuration or reduce repositioning can create value beyond the device’s direct clinical function. Integrated OR platforms increasingly allow centralized routing of surgical video, device control, documentation and communication.

The sixth driver is surgical smoke management. Electrosurgery, lasers and other energy devices produce surgical plume, making smoke evacuation increasingly relevant to perioperative safety. Historical occupational-health research found that only a minority of surveyed personnel working close to electrosurgery reported consistent local smoke evacuation, while more than half a million healthcare workers have been estimated to experience occupational exposure to surgical smoke. This creates an equipment opportunity for integrated insufflation and smoke evacuation systems, particularly as hospital policies and state-level regulation become more demanding.

The seventh driver is multidisciplinary capital utilization. Hospital executives increasingly favor platforms that can serve multiple specialties. A visualization system capable of general surgery, urology, gynecology, thoracic surgery and ENT has a stronger utilization case than a single-specialty platform. Similarly, robotic systems that obtain broader procedural indications can spread capital costs across more surgeons and operating-room days.

The final driver is surgeon recruitment and competitive positioning. High-volume surgeons can influence referral flows and hospital service-line economics. Advanced robotic, visualization and integrated OR capabilities increasingly serve as recruitment and retention tools for health systems competing for surgical talent. Capital equipment can therefore create strategic value beyond the direct procedure margin.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

The most important innovation cycle is occurring in soft-tissue surgical robotics. Intuitive received U.S. FDA clearance for the fifth-generation da Vinci 5 system in March 2024. The platform has accelerated the replacement cycle within established robotic programs while also strengthening expectations around computing capacity, force feedback, workflow integration and data generation.

Competition increased materially when Medtronic received FDA clearance for the Hugo robotic-assisted surgery system in December 2025 for minimally invasive urologic procedures including prostatectomy, nephrectomy and cystectomy. Those procedures represent an addressable pool of roughly 230,000 U.S. surgeries annually. U.S. clinical deployment began in 2026, introducing another major global medtech company into the domestic soft-tissue robotic capital market.

The competitive structure changed again in July 2026 when Johnson & Johnson received U.S. FDA De Novo authorization for OTTAVA. The system was authorized for multiple upper-abdominal general-surgery procedures, including gastric bypass, gastrectomy, cholecystectomy, gastric sleeve, appendectomy and other procedures. Its table-integrated architecture is strategically important because room footprint and workflow constraints have historically limited robotics in smaller ORs.

Visualization is advancing at the same time. Surgical cameras are moving toward 4K resolution, enhanced color reproduction, high dynamic range, fluorescence imaging and modality-specific visualization. Stryker’s 1788 platform, for example, was developed as a multispecialty MIS visualization platform with advanced fluorescence capabilities and expanded device control.

Artificial intelligence is expected to become an increasingly important layer over surgical video. Instead of replacing the surgeon, near-term AI value is likely to arise from workflow documentation, anatomy recognition, procedure-phase identification, instrument tracking, quality review, case indexing and retrospective analytics. Over time, validated real-time decision-support functions could become meaningful differentiators for premium surgical platforms.

Integrated operating rooms are also progressing beyond video routing. Future systems will connect surgical displays, robotic platforms, endoscopy towers, imaging systems, operating tables, energy devices, recording infrastructure and hospital information systems. The commercial opportunity therefore extends beyond hardware toward software, interoperability and recurring digital service revenue.

Single-use and simplified-access technologies represent another innovation pathway. Although reusable endoscopes and instruments remain economically attractive in high-volume environments, sterilization capacity, infection-control requirements and reprocessing labor can change lifecycle economics. Manufacturers are increasingly developing product configurations that allow hospitals to select reusable, disposable or hybrid models according to procedural volume and infection-control priorities.

Innovation is also being directed toward smaller robotic footprints, modular arms and flexible room configuration. This matters because many U.S. operating rooms were designed before robotic systems became mainstream. Systems capable of fitting existing OR architecture can reduce renovation requirements and shorten the capital approval cycle.

 

Segmentation Insights

The U.S. Minimally Invasive Surgery Operating Room Equipment Market is segmented on the basis of equipment type, surgical specialty, procedure platform, end user and region. These five segmentation layers reflect how hospitals actually evaluate technology: what equipment is purchased, which service lines use it, how procedures are performed, where the technology is deployed and where geographic demand is concentrated.

 

By Equipment Type

Surgical Visualization and Endoscopy Systems

Surgical visualization and endoscopy systems represent the largest equipment category, accounting for an estimated 32%–34% of 2025 market revenue, equivalent to approximately USD 3.8–4.0 billion within the defined market scope. The segment includes surgical cameras, video processors, rigid and flexible scopes used in operative workflows, light sources, monitors, fluorescence systems, image-management equipment and visualization towers.

Demand is driven by replacement of aging HD platforms, increasing utilization of 4K and fluorescence imaging and hospital efforts to standardize visualization across multiple specialties. Unlike large robotic capital purchases, visualization systems have a broader installed base and support a much larger number of operating rooms, giving the category durable replacement revenue.

Robotic-Assisted Surgery Systems

Robotic-assisted surgery systems account for an estimated 26%–28% of 2025 market value and represent the fastest-growing major capital-equipment segment. Revenue includes robotic platforms, system-related capital accessories and equipment directly tied to robotic OR infrastructure.

Growth through 2035 is expected to outpace the market average because hospitals are simultaneously expanding robotic capacity, replacing earlier-generation systems and evaluating new competing platforms. Multi-vendor competition should also create more flexible acquisition models including leasing, usage-based contracting and enterprise agreements.

Electrosurgical and Advanced Energy Equipment

Advanced energy equipment represents approximately 15%–17% of 2025 revenue. This segment includes generators and reusable system hardware supporting bipolar energy, ultrasonic energy, vessel sealing, electrosurgery and related minimally invasive tissue-management technologies.

Energy equipment benefits from high procedural utilization because it is fundamental to tissue dissection, coagulation and vessel sealing across general surgery, gynecology, urology, bariatrics and other specialties. Future differentiation will increasingly depend on intelligent energy delivery, compatibility with robotic platforms and integration with smoke-management workflows.

Insufflation, Smoke Evacuation and Fluid-Management Systems

This segment represents approximately 8%–10% of market value. Insufflation is indispensable to many laparoscopic procedures, while smoke evacuation is becoming more important as hospitals strengthen perioperative occupational-safety programs. Integrated systems capable of maintaining pneumoperitoneum while filtering smoke and stabilizing pressure can command premium pricing because they address both surgical visibility and staff exposure.

Integrated OR, Imaging and Navigation Systems

Integrated OR, imaging and navigation equipment contributes approximately 14%–16% of market value. The category includes operating-room integration platforms, surgical video routing, recording systems, surgical displays, image-guided navigation and selected intraoperative imaging infrastructure used primarily to support minimally invasive procedures.

This segment is expected to grow as hospitals redesign ORs around digital connectivity rather than standalone equipment. Large health systems increasingly want standardized room architectures that can support surgical video, remote consultation, procedure recording, device control and data capture through a common infrastructure.

 

By Surgical Specialty

General and Gastrointestinal Surgery

General and gastrointestinal surgery represent the largest surgical-specialty demand pool, accounting for an estimated 29%–31% of 2025 market revenue. Laparoscopic and robotic cholecystectomy, hernia repair, colorectal surgery, appendectomy, bariatric surgery, fundoplication and other abdominal procedures create significant demand for visualization, insufflation, energy and robotic equipment.

General surgery is especially important to robotic market expansion because its procedure base is substantially larger than many of the specialties in which robotics originally gained adoption. U.S. robotic general-surgery procedure volume has continued to grow rapidly, strengthening utilization economics for hospitals with multi-specialty robotic programs.

Urology

Urology represents approximately 17%–19% of market revenue. Robotic prostatectomy remains a foundational procedure for soft-tissue robotics, while nephrectomy, cystectomy and other minimally invasive urologic procedures support ongoing capital utilization.

The arrival of additional FDA-cleared robotic competitors is particularly relevant to urology because urologic indications provide an entry route into established robotic service lines. Hospitals may increasingly use urology as the first specialty when evaluating new robotic platforms before expanding into general surgery and gynecology.

Gynecology

Gynecology represents approximately 14%–16% of market value, with demand generated by hysterectomy, myomectomy, endometriosis surgery, adnexal procedures and gynecologic oncology. Both conventional laparoscopy and robotic-assisted surgery are deeply established in this specialty.

The segment favors equipment that provides strong visualization in confined anatomy, precise energy control and ergonomic advantages during complex pelvic procedures. Gynecologic programs also represent attractive targets for fluorescence imaging and advanced digital surgical workflows.

Orthopedics and Spine

Orthopedics and spine contribute approximately 17%–19% of market value when arthroscopy, minimally invasive spine navigation and robotic or image-guided procedure equipment are included. Knee and shoulder arthroscopy remain established outpatient procedures, while minimally invasive spine surgery is increasing demand for navigation, intraoperative imaging and robotic guidance.

This segment differs from soft-tissue MIS because navigation accuracy, implant planning and image guidance often drive the capital decision more strongly than endoscopic visualization alone.

Thoracic, Cardiovascular, ENT and Other MIS Specialties

The remaining 18%–20% of market value arises from thoracic surgery, selected cardiac procedures, ENT, neurosurgery and other minimally invasive applications. These procedures are smaller in aggregate volume but frequently require premium equipment because anatomical access is demanding and procedural complexity is high.

Expansion of robotic indications into thoracic and selected cardiac procedures could increase the capital intensity of this segment during the forecast period.

 

By Procedure Platform

Conventional Laparoscopic Surgery

Conventional laparoscopy remains the largest procedure-platform segment, representing approximately 33%–35% of 2025 market revenue. Its installed infrastructure is extensive and the procedure economics remain attractive for routine general surgery, gynecology and urology.

Despite rapid robotic growth, laparoscopy will remain essential through 2035 because it requires lower capital investment and can provide excellent clinical economics for standardized, high-volume procedures. Hospitals are therefore unlikely to replace laparoscopy with robotics universally; instead, both platforms will coexist according to case complexity and surgeon preference.

Robotic-Assisted Surgery

Robotic-assisted surgery accounts for approximately 27%–29% of current market value and is forecast to gain the most share through 2035. The segment combines premium capital pricing with recurring demand for upgrades, system expansion and room infrastructure.

The next phase of growth will depend less on proving that robotic surgery can be performed and more on proving that each incremental system produces acceptable utilization. Hospitals will increasingly compare annual case volume, room footprint, turnover time, service cost and surgeon adoption when selecting platforms.

Endoscopic Surgery

Operative endoscopic technologies account for approximately 17%–19% of the market, spanning gastrointestinal, ENT, urology and other specialties. Growth is supported by advanced therapeutic procedures and improvements in visualization.

Arthroscopic Surgery

Arthroscopic platforms represent approximately 10%–12% of market revenue. Orthopedic ASCs are particularly important customers because arthroscopy is well suited to outpatient delivery and requires specialized visualization, fluid management, shaver systems and energy equipment.

Image-Guided and Percutaneous MIS

Image-guided and percutaneous surgical approaches account for the remaining 7%–9%. This is a smaller but technology-intensive segment, with growth linked to navigation, fusion imaging, advanced displays and digitally integrated surgical planning.

 

By End User

Acute-Care Hospitals and Integrated Health Systems

Acute-care hospitals remain the largest end-user group and account for more than half of market revenue. High-acuity procedures, robotics, complex laparoscopy, advanced thoracic surgery and integrated OR projects require the infrastructure, anesthesia support and multidisciplinary staffing found in hospital settings.

Large integrated delivery networks have particularly strong purchasing power. They increasingly standardize equipment across facilities, negotiate system-level service contracts and require manufacturers to provide utilization analytics, training and lifecycle support.

Hospital Outpatient Departments

Hospital outpatient departments represent an increasingly important MIS equipment customer group. They benefit from hospital infrastructure while supporting same-day surgery economics. Health systems are investing in outpatient campuses to move appropriate procedures away from expensive inpatient environments without losing institutional control of surgical volume.

Ambulatory Surgery Centers

ASCs represent approximately one-fifth of the addressable 2025 market and are expected to gain share. The U.S. has more than 6,500 Medicare-certified ASCs, creating a highly fragmented but strategically important equipment customer base.

ASC purchasing criteria differ from tertiary hospitals. Equipment must usually produce high room utilization, predictable maintenance expense and fast payback. Compact visualization systems, arthroscopy equipment, energy platforms, endoscopy, efficient insufflation and appropriately designed robotics are particularly attractive.

Specialty Surgical Hospitals

Specialty hospitals account for a smaller but high-value segment, particularly in orthopedic, spine, cardiovascular and surgical oncology service lines. Concentrated procedure volume can justify premium technology because equipment utilization is often higher than in diversified community hospitals.

Office-Based and Interventional Surgical Facilities

Office-based procedure suites remain the smallest end-user segment but offer long-term opportunity as technology enables selected interventions to move further outside traditional hospitals. Capital footprint, ease of use, disposable economics and limited infrastructure requirements are critical purchasing factors.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Minimally Invasive Surgery Operating Room Equipment Market is geographically segmented into the South, West, Northeast and Midwest. Regional performance differs materially because MIS equipment demand is determined not only by population but also by hospital concentration, ASC penetration, specialist availability, health-system capital investment, procedure complexity, payer mix, demographic growth and regional adoption of robotic surgery.

The South is estimated to be the largest regional market in 2025 at approximately USD 4.22 billion, followed by the West at USD 2.76 billion, the Northeast at USD 2.62 billion, and the Midwest at USD 2.20 billion. Through 2035, the West is expected to produce the highest percentage growth, while the South should remain the largest absolute revenue opportunity.

South

The South represents approximately 35.8% of the U.S. market in 2025, with estimated revenue of USD 4.22 billion. At a projected regional CAGR of approximately 9.8%, the market could approach USD 10.75 billion by 2035.

The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia, together with the District of Columbia under the standard Census-region framework.

Texas and Florida form the region’s largest commercial centers. Texas combines large surgical volumes with major medical hubs in Houston, Dallas–Fort Worth, Austin and San Antonio. The state had approximately 516 Medicare-certified ASCs in March 2025, providing manufacturers with an unusually broad customer base spanning hospital systems and independent outpatient facilities.

Florida is equally important because of its large population, older demographic profile and substantial ASC infrastructure. The state had approximately 536 Medicare-certified ASCs, making it one of the largest outpatient surgical markets in the country. Aging-related demand supports minimally invasive general surgery, urology, gynecology and orthopedic procedures as well as replacement of surgical visualization equipment.

Georgia is another high-value state, with approximately 424 Medicare-certified ASCs, while Maryland had about 358. These unusually dense outpatient ecosystems strengthen demand for endoscopy towers, arthroscopic visualization, electrosurgical systems and compact OR technology.

North Carolina and Tennessee benefit from growing metropolitan populations and major referral systems, while Virginia combines sophisticated health systems with expanding suburban surgical demand. South Carolina continues to benefit from population migration and retirement-driven healthcare utilization.

Alabama, Mississippi, Louisiana, Kentucky, Arkansas and West Virginia are smaller capital markets but remain commercially relevant because regional hospital networks are modernizing surgical infrastructure while referring complex robotic cases to larger centers. Oklahoma represents a mid-sized market supported by Oklahoma City and Tulsa.

The South’s long-term advantage is therefore scale. Manufacturers can address premium academic centers, rapidly expanding suburban hospitals and high-volume ASCs within the same region. Population growth and continued facility expansion should allow the South to preserve the largest absolute revenue contribution through 2035.

West

The West is estimated at USD 2.76 billion in 2025, representing approximately 23.4% of the national market. With a projected CAGR of approximately 10.4%, regional revenue could reach around USD 7.42 billion by 2035, making the West the fastest-growing major U.S. geography.

The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.

California is the dominant state and one of the most important MIS equipment markets in the world. It had approximately 933 Medicare-certified ASCs in March 2025, substantially more than any other U.S. state. California also combines large academic health systems, major community hospital networks, extensive outpatient infrastructure and a technology-oriented provider ecosystem.

This environment supports rapid adoption of robotic surgery, fluorescence visualization, digital OR integration and AI-enabled surgical workflow. California also functions as an important early-adoption market for emerging medtech companies because major academic centers can generate clinical evidence and physician advocacy.

Arizona is one of the region’s strongest growth opportunities, supported by population expansion, retirement migration and approximately 246 Medicare-certified ASCs. Nevada has a smaller facility base but benefits from rapid metropolitan growth. Colorado combines strong integrated health systems with academic medicine and approximately 134 certified ASCs.

Washington and Oregon provide mature surgical markets with strong adoption of digitally connected healthcare infrastructure. Washington had about 169 Medicare-certified ASCs, while Oregon had roughly 92 in the 2025 facility dataset. Utah and Idaho are smaller but benefit from above-average population expansion and increasingly sophisticated regional hospital networks.

New Mexico, Montana, Wyoming, Alaska and Hawaii have lower absolute equipment demand because of smaller populations and geographic dispersion. However, these characteristics strengthen demand for centralized referral centers and equipment that can support several surgical specialties through one capital platform.

The West’s projected growth premium reflects the intersection of population migration, technology adoption, outpatient expansion and sophisticated hospital capital investment.

Northeast

The Northeast is estimated at approximately USD 2.62 billion in 2025, representing about 22.2% of the U.S. market. Regional growth is projected at approximately 9.1% annually, taking the market toward USD 6.26 billion by 2035.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island and Vermont.

New York represents the largest absolute surgical market in the Northeast because of its population, tertiary-care infrastructure and high concentration of complex academic hospitals. The state had approximately 192 Medicare-certified ASCs in 2025, but its market value is disproportionately supported by hospital-based surgery and high-acuity procedures.

New Jersey and Pennsylvania have especially substantial outpatient infrastructure, with approximately 251 and 241 Medicare-certified ASCs, respectively. These markets combine community hospital systems with high outpatient procedure density, making them attractive for both premium capital systems and high-throughput conventional MIS equipment.

Massachusetts has a smaller population but outsized influence on surgical innovation because Boston contains several internationally recognized academic medical centers and medtech research networks. New technologies frequently gain early clinical validation in this environment.

Connecticut and New Hampshire offer mature, relatively affluent surgical markets. Rhode Island and Maine are smaller but support concentrated hospital systems capable of adopting premium visualization and integrated OR systems. Vermont has a very small ASC footprint and relies more heavily on hospital-centered surgical delivery.

The Northeast is unlikely to match Western population-driven growth, but revenue per complex surgical case remains attractive. Hospitals in this region often serve as reference centers for advanced robotics, image-guided surgery and multidisciplinary minimally invasive programs. As a result, evidence generation and clinical influence can make the region strategically more important than its market share alone suggests.

Midwest

The Midwest generated an estimated USD 2.20 billion in 2025, representing approximately 18.6% of the national market. With projected growth of approximately 8.8% annually, the regional market could reach USD 5.11 billion by 2035.

The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin.

Illinois and Ohio are the largest commercial markets in the region. Chicago supports major academic medical centers, large integrated provider organizations and high procedural volumes. Ohio combines leading tertiary centers with substantial community-hospital infrastructure and approximately 215 Medicare-certified ASCs.

Michigan remains important for high-volume general surgery, urology and orthopedic care. Minnesota carries additional strategic significance because of its medtech ecosystem and concentration of sophisticated surgical providers.

Indiana, Wisconsin and Missouri represent stable mid-sized markets supported by established hospital networks and relatively broad outpatient capacity. Iowa, Kansas and Nebraska provide smaller but durable surgical equipment demand, often emphasizing cost-efficient technology, vendor service coverage and equipment reliability.

North Dakota and South Dakota have small populations and approximately 15 Medicare-certified ASCs each. In these states, regional referral models concentrate complex minimally invasive procedures within a relatively limited number of facilities.

The Midwest is expected to grow more slowly than the South and West, but it remains commercially attractive because of large replacement cycles and relatively stable procedure demand. Manufacturers that combine strong clinical training, responsive technical service and enterprise contracting can build durable positions in this region.

 

Key Market Players

The U.S. Minimally Invasive Surgery Operating Room Equipment competitive landscape is increasingly characterized by platform competition rather than isolated device competition. Manufacturers that can combine visualization, robotics, energy, integration, instruments, data and service capability have a structural advantage in enterprise hospital contracting.

Some of the most relevant companies operating across the U.S. market are Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, Olympus Corporation, KARL STORZ, CONMED Corporation, Boston Scientific Corporation, B. Braun, Smith+Nephew, Zimmer Biomet, Arthrex, STERIS, Getinge, GE HealthCare, Siemens Healthineers, Philips, Fujifilm Healthcare Americas, Richard Wolf, Applied Medical, Teleflex, Cook Medical, Brainlab and Ambu.

Intuitive remains the benchmark competitor in soft-tissue surgical robotics because of its installed base, procedure ecosystem, surgeon training infrastructure and recurring instruments-and-accessories model. The transition toward da Vinci 5 extends this platform advantage while creating an equipment replacement cycle.

Medtronic is becoming more strategically significant following U.S. authorization of Hugo. Its broader position in laparoscopy, advanced energy, stapling and digital surgery allows the company to compete around a connected surgical ecosystem rather than robotics alone.

Johnson & Johnson MedTech adds another major competitive force following U.S. authorization of OTTAVA in 2026. Its presence in Ethicon surgical instruments, energy and stapling creates potential for portfolio integration, while OTTAVA’s table-integrated architecture provides differentiation around operating-room footprint and workflow.

Stryker is particularly strong in surgical visualization, integrated OR systems, fluorescence imaging, arthroscopy and related operating-room infrastructure. Olympus and KARL STORZ remain highly influential in endoscopy, surgical imaging and minimally invasive visualization, while CONMED competes across energy, laparoscopy and surgical equipment.

STERIS and Getinge are strategically important where integrated OR infrastructure intersects with room design, infection prevention and workflow. GE HealthCare, Siemens Healthineers and Philips contribute imaging and image-guided technologies that become increasingly relevant as minimally invasive procedures depend more heavily on intraoperative data.

Smith+Nephew, Arthrex and Zimmer Biomet have significant positions in orthopedic and arthroscopic surgical ecosystems. Brainlab is important in navigation and digitally enabled image-guided surgery. Fujifilm, Richard Wolf and Ambu provide additional competitive pressure within visualization and endoscopic technologies.

Competitive advantage through 2035 will depend on FDA clearances, breadth of procedural indications, surgeon training capability, service response, uptime, interoperability, disposable economics, financing flexibility and the ability to demonstrate measurable improvements in operating-room utilization.

 

Recent Developments

The U.S. market entered a new robotic competition cycle in March 2024, when Intuitive received FDA clearance for the da Vinci 5 system. The platform introduced a fifth-generation architecture into an already large installed base and accelerated capital replacement among high-volume robotic centers.

In December 2025, Medtronic received FDA clearance for Hugo for minimally invasive urologic surgery. This was strategically important because it introduced a major alternative soft-tissue robotic platform into the U.S. market. The first U.S. Hugo procedures followed in 2026, while the company continued work toward broader general-surgery and gynecologic indications.

Robotic competition intensified in July 2026, when Johnson & Johnson received FDA De Novo authorization for OTTAVA. Authorization covered multiple upper-abdominal general-surgery procedures. The table-integrated design is relevant to hospital economics because reducing equipment footprint may allow more existing ORs to accommodate robotic procedures without extensive architectural modification. Prior clinical work demonstrated use across rooms ranging from approximately 243 to 694 square feet.

Visualization innovation has also advanced. Newer surgical camera platforms combine 4K imaging, higher dynamic range and fluorescence capability, giving surgeons more detailed intraoperative information without adding entirely separate imaging systems.

Outpatient reimbursement remains another important market development. CMS continues to update hospital outpatient and ASC payment policies annually, while the number of Medicare-certified ASCs continues to grow. This policy environment reinforces manufacturer interest in technology designed specifically for high-throughput outpatient surgery.

The competitive focus is consequently shifting from individual equipment performance toward connected surgical ecosystems. Manufacturers increasingly want to control a larger portion of the procedural workflow, including imaging, energy delivery, robotics, accessories, video management, analytics and surgeon training.

 

Conclusion

The U.S. Minimally Invasive Surgery Operating Room Equipment Market Size & Share is positioned to expand from approximately USD 11.80 billion in 2025 to USD 29.51 billion by 2035, representing a 9.60% CAGR during 2026–2035.

This growth outlook is supported by the continuing conversion from open to minimally invasive procedures, rapid expansion of robotic-assisted surgery, replacement of aging surgical visualization platforms, increasing utilization of fluorescence and digitally enhanced imaging, outpatient procedure migration, greater emphasis on surgical smoke control and the development of connected operating-room infrastructure.

The most important market transition over the next decade will be from equipment procurement to surgical-platform procurement. Historically, hospitals could purchase cameras, insufflators, energy systems, displays and instruments as relatively independent assets. Increasingly, clinical and economic value will depend on how those systems interact.

Robotic surgery will generate the highest-profile capital competition. Intuitive’s established installed base will increasingly be challenged by Medtronic and Johnson & Johnson as newer systems penetrate U.S. hospitals. Competition is likely to improve commercial flexibility and may accelerate adoption among facilities that previously found single-platform robotics economically restrictive.

Visualization will remain one of the largest recurring equipment opportunities. 4K imaging, fluorescence, digital enhancement, high-dynamic-range displays and surgical data capture are becoming central to minimally invasive workflow. Unlike robotics, visualization affects nearly every minimally invasive operating room and therefore creates a broad replacement market.

The outpatient channel will become increasingly important. More than 6,500 Medicare-certified ASCs already provide a significant installed customer base, and continued migration of appropriate procedures will require equipment optimized for smaller footprints, rapid turnover and disciplined capital economics.

Regionally, the South should remain the largest market, supported by Texas, Florida, Georgia, North Carolina and other population-growth states. The West is expected to record the fastest percentage expansion, led by California, Arizona, Colorado and Washington. The Northeast will retain strategic importance in premium technology adoption and clinical evidence generation, while the Midwest will provide stable replacement and procedure-driven demand.

At the state level, California, Texas and Florida represent exceptional commercial opportunities because they combine very large populations with extensive hospital and ASC infrastructure. Georgia, Maryland, New Jersey, Pennsylvania and Arizona also provide unusually large outpatient surgical ecosystems, while New York, Massachusetts, Illinois, Ohio and Minnesota remain influential through major tertiary and academic surgical programs.

For manufacturers, investors, distributors and hospital strategy teams evaluating this industry, the key question is not simply how fast minimally invasive surgery will grow. The more commercially relevant issue is which operating-room technologies will earn incremental capital budgets by improving procedure economics.

Systems that increase room utilization, reduce setup complexity, fit existing OR architecture, improve visualization, enable cross-specialty use, support outpatient workflows and produce clinically meaningful data will be best positioned to capture value.

By 2035, leadership in the U.S. minimally invasive surgery operating room equipment industry will therefore be defined less by ownership of an individual device category and more by the ability to create a reliable, interoperable and economically defensible surgical ecosystem.

 

TABLE OF CONTENT

1. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Minimally Invasive Surgery Equipment Manufacturers
1.6.2. Surgical Robotics and Visualization Platform Manufacturers
1.6.3. Component, Optics, Imaging and Contract Manufacturing Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Surgical Hospitals
1.6.6. Ambulatory Surgery Centers and Outpatient Surgical Facilities
1.6.7. Group Purchasing Organizations and Medical Device Distributors
1.6.8. Surgeons, Perioperative Teams and Value Analysis Committees
1.6.9. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the U.S. minimally invasive surgery operating room equipment market boundary, equipment categories, methodology, assumptions and stakeholder ecosystem so clients understand how market revenue is measured, validated and forecast.

2. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025 vs. 2035
2.8. High-Growth Equipment Categories
2.9. High-Growth Surgical Specialties
2.10. High-Growth U.S. Regional Opportunities
2.11. Key Capital Procurement Themes

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical development, growth concentration, technology adoption, competitive intensity and the equipment categories expected to generate the strongest opportunities through 2035.

3. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Adoption of Minimally Invasive Surgical Procedures
3.1.2. Expansion of Robotic-Assisted Surgery Across Surgical Specialties
3.1.3. Migration of Eligible Surgical Procedures to Outpatient Settings
3.1.4. Replacement of Aging Surgical Visualization and Endoscopy Platforms
3.1.5. Adoption of 4K, 3D and Fluorescence-Guided Surgical Imaging
3.1.6. Hospital Focus on Operating Room Throughput and Efficiency
3.1.7. Growth of Integrated and Digitally Connected Operating Rooms
3.1.8. Increasing Surgical Smoke Management and Occupational Safety Requirements
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced MIS and Robotic Systems
3.2.2. High Maintenance, Service and Consumable Costs
3.2.3. Hospital Capital Budget Constraints
3.2.4. Complex Surgeon and Operating Room Staff Training Requirements
3.2.5. Limited Utilization Economics in Low-Volume Surgical Facilities
3.2.6. Reprocessing and Sterilization Complexity
3.2.7. Product Recall, Cybersecurity and Equipment Reliability Risks
3.3. Opportunities and Their Impact Analysis
3.3.1. Next-Generation Soft-Tissue Surgical Robotics
3.3.2. Expansion of Robotic Surgery into General Surgery
3.3.3. Compact and ASC-Oriented Surgical Equipment Platforms
3.3.4. AI-Assisted Surgical Visualization and Workflow Analytics
3.3.5. Fluorescence-Guided and Enhanced Visualization Systems
3.3.6. Integrated Insufflation and Surgical Smoke Evacuation
3.3.7. Enterprise-Wide OR Standardization by Integrated Delivery Networks
3.3.8. Equipment Leasing, Managed Services and Procedure-Based Commercial Models
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Minimally Invasive Surgical Procedure Volume Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Operating Room Utilization and Turnover Economics
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Ambulatory Surgery Center Equipment Economics
3.11. Installed-Base Replacement Cycle Analysis

What this section provides: This section explains the clinical, operational, economic and capital-procurement forces determining adoption of minimally invasive surgery operating room equipment and helps clients assess growth opportunities alongside execution, utilization and reimbursement risks.

4. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Capital Equipment Average Selling Price Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. Surgical Equipment Installed-Base and Replacement Dynamics
4.7. Impact of Digitalization and Connected Operating Rooms
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.10. CMS Reimbursement and Coverage Landscape
4.11. Hospital Outpatient and ASC Reimbursement Environment
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Healthcare Initiatives and Surgical Quality Programs
4.14. Impact of Escalating Geopolitical and Supply Chain Tensions
4.15. Hospital Value Analysis Committee Decision Framework
4.16. Capital Equipment ROI and Total Cost of Ownership Analysis

What this section provides: This section provides a comprehensive view of regulation, reimbursement, pricing, supply-chain risk, technology adoption, total cost of ownership, hospital purchasing behavior and the external environment affecting MIS operating room equipment demand.

5. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By Equipment Type

5.1. Overview
5.1.1. Segment Share Analysis, By Equipment Type, 2025 & 2035 (%)
5.1.2. Surgical Visualization and Endoscopy Systems
5.1.2.1. Surgical Camera Systems
5.1.2.2. Rigid and Flexible Surgical Endoscopes
5.1.2.3. Video Processors and Control Units
5.1.2.4. Surgical Light Sources
5.1.2.5. 4K and Ultra-High-Definition Visualization Systems
5.1.2.6. 3D Surgical Visualization Systems
5.1.2.7. Fluorescence-Guided Imaging Systems
5.1.2.8. Surgical Displays and Monitors
5.1.2.9. Image Capture and Documentation Systems
5.1.3. Robotic-Assisted Surgery Systems
5.1.3.1. Surgeon Consoles
5.1.3.2. Patient-Side Robotic Systems
5.1.3.3. Robotic Arms and Manipulators
5.1.3.4. Robotic Vision Systems
5.1.3.5. Robotic System Accessories and Capital Components
5.1.4. Electrosurgical and Advanced Energy Equipment
5.1.4.1. Electrosurgical Generators
5.1.4.2. Advanced Bipolar Energy Systems
5.1.4.3. Ultrasonic Energy Systems
5.1.4.4. Vessel Sealing Systems
5.1.4.5. Combination Energy Platforms
5.1.5. Insufflation, Smoke Evacuation and Fluid Management Systems
5.1.5.1. Laparoscopic Insufflation Systems
5.1.5.2. Integrated Insufflation and Smoke Evacuation Systems
5.1.5.3. Standalone Surgical Smoke Evacuation Systems
5.1.5.4. Arthroscopic and Endoscopic Fluid Management Systems
5.1.6. Integrated OR, Surgical Imaging and Navigation Systems
5.1.6.1. Integrated Operating Room Platforms
5.1.6.2. Surgical Video Routing and Control Systems
5.1.6.3. Intraoperative Imaging Systems
5.1.6.4. Surgical Navigation Systems
5.1.6.5. Digital Surgical Workflow Platforms

What this section provides: This section identifies the MIS operating room equipment categories expected to generate the largest revenue pools, strongest replacement demand and highest technology-driven growth through 2035.

6. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By Surgical Specialty

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Specialty, 2025 & 2035 (%)
6.1.2. General and Gastrointestinal Surgery
6.1.2.1. Cholecystectomy
6.1.2.2. Hernia Repair
6.1.2.3. Colorectal Surgery
6.1.2.4. Bariatric Surgery
6.1.2.5. Appendectomy
6.1.2.6. Hepatobiliary and Other Abdominal Surgery
6.1.3. Urology
6.1.3.1. Prostatectomy
6.1.3.2. Nephrectomy
6.1.3.3. Cystectomy
6.1.3.4. Other Minimally Invasive Urologic Procedures
6.1.4. Gynecology
6.1.4.1. Hysterectomy
6.1.4.2. Myomectomy
6.1.4.3. Endometriosis Surgery
6.1.4.4. Gynecologic Oncology Procedures
6.1.4.5. Other Minimally Invasive Gynecologic Procedures
6.1.5. Orthopedics and Spine
6.1.5.1. Knee Arthroscopy
6.1.5.2. Shoulder Arthroscopy
6.1.5.3. Hip Arthroscopy
6.1.5.4. Minimally Invasive Spine Surgery
6.1.5.5. Image-Guided and Robotic Orthopedic Procedures
6.1.6. Thoracic, Cardiovascular, ENT, Neurosurgery and Other Specialties
6.1.6.1. Thoracic Surgery
6.1.6.2. Minimally Invasive Cardiovascular Surgery
6.1.6.3. ENT Surgery
6.1.6.4. Neurosurgery
6.1.6.5. Other Minimally Invasive Surgical Specialties

What this section provides: This section evaluates demand by surgical specialty, allowing clients to identify procedure categories with strong MIS penetration, robotic adoption, equipment intensity and future capital-investment potential.

7. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By Procedure Platform

7.1. Overview
7.1.1. Segment Share Analysis, By Procedure Platform, 2025 & 2035 (%)
7.1.2. Conventional Laparoscopic Surgery
7.1.2.1. Multi-Port Laparoscopic Surgery
7.1.2.2. Reduced-Port Laparoscopic Surgery
7.1.2.3. Single-Incision Laparoscopic Surgery
7.1.3. Robotic-Assisted Surgery
7.1.3.1. Multi-Port Robotic Surgery
7.1.3.2. Single-Port Robotic Surgery
7.1.3.3. Modular Robotic Surgery Platforms
7.1.4. Endoscopic Surgery
7.1.4.1. Rigid Endoscopic Surgery
7.1.4.2. Flexible Endoscopic Surgery
7.1.4.3. Advanced Therapeutic Endoscopy
7.1.5. Arthroscopic Surgery
7.1.5.1. Knee Arthroscopy
7.1.5.2. Shoulder Arthroscopy
7.1.5.3. Hip and Other Arthroscopic Procedures
7.1.6. Image-Guided and Percutaneous Minimally Invasive Surgery
7.1.6.1. Navigation-Guided Surgery
7.1.6.2. Image-Guided Percutaneous Procedures
7.1.6.3. Intraoperative Imaging-Assisted Procedures

What this section provides: This section compares the major MIS procedure platforms and helps clients understand where conventional laparoscopy, robotics, endoscopy, arthroscopy and image-guided surgery are gaining or losing share.

8. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Acute-Care Hospitals and Integrated Health Systems
8.1.2.1. Large Integrated Delivery Networks
8.1.2.2. Community Hospitals
8.1.2.3. Tertiary and Quaternary Referral Hospitals
8.1.3. Academic Medical Centers
8.1.3.1. University-Affiliated Hospitals
8.1.3.2. Teaching and Research Hospitals
8.1.4. Hospital Outpatient Departments
8.1.4.1. Main Campus Outpatient Surgical Departments
8.1.4.2. Off-Campus Hospital Outpatient Surgical Facilities
8.1.5. Ambulatory Surgery Centers
8.1.5.1. Multispecialty ASCs
8.1.5.2. Orthopedic and Spine ASCs
8.1.5.3. GI and General Surgery ASCs
8.1.5.4. Urology and Gynecology ASCs
8.1.6. Specialty Surgical Hospitals and Office-Based Facilities
8.1.6.1. Orthopedic Specialty Hospitals
8.1.6.2. Surgical Specialty Hospitals
8.1.6.3. Office-Based Surgical and Interventional Facilities

What this section provides: This section identifies the care settings generating MIS operating room equipment demand and explains differences in capital budgets, room utilization, purchasing criteria and technology adoption across hospitals, academic centers and outpatient facilities.

9. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Medical Equipment Sales
9.1.6. Ambulatory Surgery Center and Specialty Facility Procurement
9.1.7. Leasing, Managed Equipment and Usage-Based Procurement Models

What this section provides: This section explains how MIS operating room equipment is purchased in the U.S., including direct capital sales, IDN standardization, GPO contracts, distribution channels, ASC purchasing and emerging leasing or procedure-based commercial models.

10. U.S. Minimally Invasive Surgery Operating Room Equipment Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Minimally Invasive Surgical Procedure Volume Analysis
10.1.4. Regional Hospital, ASC and Operating Room Infrastructure Analysis
10.1.5. Regional Robotic Surgery Installed-Base Analysis
10.1.6. Regional Capital Procurement and Reimbursement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Equipment Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Procedure Platform, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states, helping clients identify surgical procedure hubs, robotic and visualization adoption hotspots, hospital and ASC infrastructure concentration, capital replacement opportunities and state-level commercial priorities.

11. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Equipment Portfolio
11.4. Surgical Robotics Competitive Benchmarking
11.5. Visualization and Integrated OR Competitive Benchmarking
11.6. Company Profiles
11.6.1. Intuitive Surgical
11.6.2. Medtronic
11.6.3. Johnson & Johnson MedTech
11.6.4. Stryker
11.6.5. Olympus Corporation
11.6.6. KARL STORZ
11.6.7. CONMED Corporation
11.6.8. Boston Scientific Corporation
11.6.9. B. Braun
11.6.10. Smith+Nephew
11.6.11. Zimmer Biomet
11.6.12. Arthrex
11.6.13. STERIS
11.6.14. Getinge
11.6.15. GE HealthCare
11.6.16. Siemens Healthineers
11.6.17. Philips
11.6.18. Fujifilm Healthcare Americas
11.6.19. Richard Wolf
11.6.20. Applied Medical
11.6.21. Teleflex
11.6.22. Cook Medical
11.6.23. Brainlab
11.6.24. Ambu
11.6.25. ERBE USA
11.7. Company Profile Parameters
11.7.1. Company Overview
11.7.2. MIS Operating Room Equipment Portfolio
11.7.3. U.S. Market Strategy
11.7.4. Financial and Commercial Positioning
11.7.5. Product Innovation and R&D Pipeline
11.7.6. FDA Regulatory Updates
11.7.7. Strategic Partnerships and Acquisitions
11.7.8. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, equipment-portfolio positioning, surgical robotics strategy, visualization capabilities, innovation direction and strategic intelligence on 25 significant companies active in the U.S. MIS operating room equipment ecosystem.

12. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Next-Generation Surgical Robotics
12.2.2. AI-Assisted Surgical Visualization
12.2.3. Fluorescence and Advanced Optical Imaging
12.2.4. Digital and Integrated Operating Rooms
12.2.5. Surgical Navigation and Intraoperative Imaging
12.2.6. Smart Energy and Automated Tissue Management
12.2.7. Integrated Insufflation and Smoke Evacuation
12.2.8. Surgical Video Analytics and Data Platforms
12.3. Future of Multi-Vendor Surgical Robotics Competition
12.4. Future of Minimally Invasive Surgery in ASCs
12.5. Capital Equipment Replacement Outlook
12.6. Emerging Business and Commercial Model Trends
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. Technology Adoption Curve, 2026–2035

What this section provides: This section prepares clients for future changes in robotics, imaging, artificial intelligence, outpatient surgery, integrated OR infrastructure, capital-equipment replacement and competitive market structure through 2035.

13. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Strategic Recommendations

13.1. Recommendations for MIS Equipment Manufacturers
13.2. Recommendations for Surgical Robotics Companies
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Ambulatory Surgery Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. U.S. Regional Market Prioritization Strategy
13.11. Hospital Value Analysis and Economic Evidence Strategy
13.12. Capital Equipment Commercialization and Pricing Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, commercialization, hospital contracting, ASC expansion, regional prioritization, investment planning and competitive differentiation.

14. U.S. Minimally Invasive Surgery Operating Room Equipment Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. Market Sizing and Modeling Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, market-sizing methodology limitations, forecasting assumptions, data-use conditions and legal considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Definition and Scope
TABLE 3: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Research Methodology Framework
TABLE 4: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Key Assumptions
TABLE 5: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Ecosystem Overview
TABLE 6: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Stakeholder Analysis
TABLE 7: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Analyst Viewpoint Summary
TABLE 9: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Attractiveness Index
TABLE 10: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Minimally Invasive Surgery Operating Room Equipment Market: High-Growth Opportunity Areas, 2026–2035
TABLE 14: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Drivers; Impact Analysis
TABLE 15: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Restraints; Impact Analysis
TABLE 16: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Opportunities; Impact Analysis
TABLE 17: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Challenges; Impact Analysis
TABLE 18: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Minimally Invasive Surgery Operating Room Equipment Market: MIS Procedure Volume Analysis
TABLE 20: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Operating Room Utilization and Turnover Economics
TABLE 22: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Minimally Invasive Surgery Operating Room Equipment Market: ASC Equipment Economics Matrix
TABLE 24: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Installed-Base Replacement Cycle Analysis
TABLE 25: U.S. Minimally Invasive Surgery Operating Room Equipment Market: PESTEL Analysis
TABLE 26: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Capital Equipment Average Selling Price Analysis
TABLE 29: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Value Chain Analysis
TABLE 30: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Supply Chain Analysis
TABLE 31: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Installed-Base and Replacement Dynamics
TABLE 32: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Digitalization and Connected OR Impact
TABLE 33: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Application & Innovation Landscape
TABLE 34: U.S. Minimally Invasive Surgery Operating Room Equipment Market: FDA Regulatory Framework Analysis
TABLE 35: U.S. Minimally Invasive Surgery Operating Room Equipment Market: CMS Reimbursement and Coverage Landscape
TABLE 36: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Hospital Outpatient and ASC Reimbursement Environment
TABLE 37: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Hospital Value Analysis and Total Cost of Ownership Framework
TABLE 39: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Equipment Type Snapshot, 2025
TABLE 40: Segment Dashboard; Definition and Scope, by Equipment Type
TABLE 41: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by Equipment Type, 2021–2035 (US$ Billion)
TABLE 42: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Segment Share Analysis, by Equipment Type, 2025 & 2035 (%)
TABLE 43: Surgical Visualization and Endoscopy Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Robotic-Assisted Surgery Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Electrosurgical and Advanced Energy Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Insufflation, Smoke Evacuation and Fluid Management Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Integrated OR, Surgical Imaging and Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. MIS Operating Room Equipment Replacement and Upgrade Opportunity Matrix
TABLE 49: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Surgical Specialty Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Surgical Specialty
TABLE 51: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 52: Segment Share Analysis, by Surgical Specialty, 2025 & 2035 (%)
TABLE 53: General and Gastrointestinal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Orthopedics and Spine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Thoracic, Cardiovascular, ENT, Neurosurgery and Other Specialties Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Surgical Specialty Procedure Intensity and Equipment Utilization Matrix
TABLE 59: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Procedure Platform Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by Procedure Platform
TABLE 61: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by Procedure Platform, 2021–2035 (US$ Billion)
TABLE 62: Segment Share Analysis, by Procedure Platform, 2025 & 2035 (%)
TABLE 63: Conventional Laparoscopic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Robotic-Assisted Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Endoscopic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Arthroscopic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Image-Guided and Percutaneous MIS Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: MIS Procedure Platform Adoption and Growth Matrix, 2025–2035
TABLE 69: U.S. Minimally Invasive Surgery Operating Room Equipment Market: End User Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by End User
TABLE 71: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 72: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 73: Acute-Care Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Specialty Surgical Hospitals and Office-Based Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: End-User Capital Procurement and Equipment Utilization Matrix
TABLE 79: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Procurement Channel Snapshot, 2025
TABLE 80: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 81: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 82: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 83: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Distributor and Specialty Medical Equipment Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: ASC and Specialty Facility Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Leasing, Managed Equipment and Usage-Based Procurement Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Regional Snapshot, 2025
TABLE 90: Segment Dashboard; Definition and Scope, by Geography
TABLE 91: U.S. Minimally Invasive Surgery Operating Room Equipment Market, by Region, 2021–2035 (US$ Billion)
TABLE 92: Regional Share Analysis, 2025 & 2035 (%)
TABLE 93: West Region U.S. Minimally Invasive Surgery Operating Room Equipment Market: Regional Overview and Trends
TABLE 94: West Region: Key Manufacturers and Procurement Ecosystem
TABLE 95: West Region Market, by State, 2021–2035 (US$ Billion)
TABLE 96: West Region Market, by Equipment Type, 2021–2035 (US$ Billion)
TABLE 97: West Region Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 98: West Region Market, by Procedure Platform, 2021–2035 (US$ Billion)
TABLE 99: West Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: West Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 101: California Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Washington Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Arizona Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Colorado Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Oregon Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Utah Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Nevada Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: New Mexico Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Idaho Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Montana Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Wyoming Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Alaska Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Hawaii Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Minimally Invasive Surgery Operating Room Equipment Market: Regional Overview and Trends
TABLE 115: Northeast Region: Key Manufacturers and Procurement Ecosystem
TABLE 116: Northeast Region Market, by State, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region Market, by Equipment Type, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region Market, by Procedure Platform, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: New York Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Massachusetts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: New Jersey Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Pennsylvania Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Connecticut Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Maine Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Vermont Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: New Hampshire Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Rhode Island Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Delaware Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Minimally Invasive Surgery Operating Room Equipment Market: Regional Overview and Trends
TABLE 133: South Region: Key Manufacturers and Procurement Ecosystem
TABLE 134: South Region Market, by State, 2021–2035 (US$ Billion)
TABLE 135: South Region Market, by Equipment Type, 2021–2035 (US$ Billion)
TABLE 136: South Region Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 137: South Region Market, by Procedure Platform, 2021–2035 (US$ Billion)
TABLE 138: South Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: South Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Texas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Florida Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Georgia Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: North Carolina Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Tennessee Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Carolina Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Alabama Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Mississippi Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Louisiana Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Arkansas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Kentucky Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Oklahoma Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Virginia Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Maryland Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: West Virginia Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Minimally Invasive Surgery Operating Room Equipment Market: Regional Overview and Trends
TABLE 156: Midwest Region: Key Manufacturers and Procurement Ecosystem
TABLE 157: Midwest Region Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region Market, by Equipment Type, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region Market, by Procedure Platform, 2021–2035 (US$ Billion)
TABLE 161: Midwest Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Illinois Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Ohio Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Michigan Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Minnesota Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Indiana Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Wisconsin Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Missouri Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Iowa Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Kansas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Nebraska Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: North Dakota Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: South Dakota Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Competitive Landscape Snapshot, 2025
TABLE 176: Key Company Market Share Analysis, 2025
TABLE 177: Company Positioning Matrix
TABLE 178: Equipment Portfolio Benchmarking of Key Players
TABLE 179: Surgical Robotics Competitive Benchmarking
TABLE 180: Visualization and Integrated OR Competitive Benchmarking
TABLE 181: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 182: Intuitive Surgical: Company Profile
TABLE 183: Medtronic: Company Profile
TABLE 184: Johnson & Johnson MedTech: Company Profile
TABLE 185: Stryker: Company Profile
TABLE 186: Olympus Corporation: Company Profile
TABLE 187: KARL STORZ: Company Profile
TABLE 188: CONMED Corporation: Company Profile
TABLE 189: Boston Scientific Corporation: Company Profile
TABLE 190: B. Braun: Company Profile
TABLE 191: Smith+Nephew: Company Profile
TABLE 192: Zimmer Biomet: Company Profile
TABLE 193: Arthrex: Company Profile
TABLE 194: STERIS: Company Profile
TABLE 195: Getinge: Company Profile
TABLE 196: GE HealthCare: Company Profile
TABLE 197: Siemens Healthineers: Company Profile
TABLE 198: Philips: Company Profile
TABLE 199: Fujifilm Healthcare Americas: Company Profile
TABLE 200: Richard Wolf: Company Profile
TABLE 201: Applied Medical: Company Profile
TABLE 202: Teleflex: Company Profile
TABLE 203: Cook Medical: Company Profile
TABLE 204: Brainlab: Company Profile
TABLE 205: Ambu: Company Profile
TABLE 206: ERBE USA: Company Profile
TABLE 207: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Future Market Scenario Analysis, 2026–2035
TABLE 208: Disruptive Technologies Impact Matrix
TABLE 209: Multi-Vendor Surgical Robotics Competition Outlook
TABLE 210: Future of Minimally Invasive Surgery in ASCs
TABLE 211: Capital Equipment Replacement Outlook, 2026–2035
TABLE 212: Emerging Business and Commercial Model Trends
TABLE 213: Business Opportunities for Startups and Existing Players
TABLE 214: Investment Prioritization Matrix
TABLE 215: Technology Adoption Curve, 2026–2035
TABLE 216: Strategic Recommendations for MIS Equipment Manufacturers
TABLE 217: Strategic Recommendations for Surgical Robotics Companies
TABLE 218: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 219: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 220: Strategic Recommendations for Investors and Private Equity Firms
TABLE 221: Strategic Recommendations for Distributors and Channel Partners
TABLE 222: Strategic Recommendations for New Entrants and Startups
TABLE 223: Go-to-Market Strategy Considerations
TABLE 224: Product Positioning and Portfolio Expansion Guidance
TABLE 225: U.S. Regional Market Prioritization Strategy
TABLE 226: Hospital Value Analysis and Economic Evidence Strategy
TABLE 227: Capital Equipment Commercialization and Pricing Strategy
TABLE 228: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Scope Limitation
TABLE 229: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Definition Limitation
TABLE 230: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Data Use Limitation
TABLE 231: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Forecasting Limitation
TABLE 232: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Market Sizing and Modeling Limitation
TABLE 233: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Legal Disclaimer
TABLE 234: U.S. Minimally Invasive Surgery Operating Room Equipment Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Minimally Invasive Surgery Operating Room Equipment Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Overview
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: Market Sizing and Forecasting Framework
FIGURE 6: Executive Market Snapshot, 2025
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Historical Market Size and Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 9: Market Size Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 10: High-Growth Opportunity Map, 2026–2035
FIGURE 11: Market Drivers Impact Analysis
FIGURE 12: Market Restraints Impact Analysis
FIGURE 13: Market Opportunities Impact Analysis
FIGURE 14: Market Challenges Impact Analysis
FIGURE 15: Innovation & Patent Landscape, 2021–2025
FIGURE 16: MIS Procedure Volume Growth Framework
FIGURE 17: Clinical Workflow Economics Framework
FIGURE 18: Operating Room Utilization and Turnover Economics
FIGURE 19: Hospital Capital Procurement Decision Framework
FIGURE 20: PESTEL Analysis
FIGURE 21: Porter’s Five Forces Analysis
FIGURE 22: Pricing Trend Analysis by Region, 2025–2035
FIGURE 23: Value Chain Analysis
FIGURE 24: Supply Chain Analysis
FIGURE 25: Installed-Base Replacement Cycle
FIGURE 26: Connected and Digitally Integrated Operating Room Framework
FIGURE 27: FDA Regulatory and CMS Reimbursement Landscape
FIGURE 28: Hospital Outpatient and ASC Reimbursement Environment
FIGURE 29: Hospital Value Analysis Committee Decision Framework
FIGURE 30: Total Cost of Ownership Framework for MIS Capital Equipment
FIGURE 31: Equipment Type Segment Market Share Analysis, 2025 & 2035
FIGURE 32: Equipment Type Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Surgical Visualization and Endoscopy Systems Market Forecast, 2021–2035
FIGURE 34: Robotic-Assisted Surgery Systems Market Forecast, 2021–2035
FIGURE 35: Electrosurgical and Advanced Energy Equipment Market Forecast, 2021–2035
FIGURE 36: Insufflation, Smoke Evacuation and Fluid Management Systems Market Forecast, 2021–2035
FIGURE 37: Integrated OR, Surgical Imaging and Navigation Systems Market Forecast, 2021–2035
FIGURE 38: Surgical Specialty Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Surgical Specialty Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: General and Gastrointestinal Surgery Equipment Market Forecast, 2021–2035
FIGURE 41: Urology Equipment Market Forecast, 2021–2035
FIGURE 42: Gynecology Equipment Market Forecast, 2021–2035
FIGURE 43: Orthopedics and Spine Equipment Market Forecast, 2021–2035
FIGURE 44: Thoracic, Cardiovascular, ENT, Neurosurgery and Other Specialties Forecast, 2021–2035
FIGURE 45: Surgical Specialty Equipment Intensity Matrix
FIGURE 46: Procedure Platform Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Procedure Platform Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 48: Conventional Laparoscopic Surgery Market Forecast, 2021–2035
FIGURE 49: Robotic-Assisted Surgery Market Forecast, 2021–2035
FIGURE 50: Endoscopic Surgery Market Forecast, 2021–2035
FIGURE 51: Arthroscopic Surgery Market Forecast, 2021–2035
FIGURE 52: Image-Guided and Percutaneous MIS Market Forecast, 2021–2035
FIGURE 53: MIS Procedure Platform Adoption Roadmap, 2025–2035
FIGURE 54: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 55: End User Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: Acute-Care Hospitals and Integrated Health Systems Market Forecast, 2021–2035
FIGURE 57: Academic Medical Centers Market Forecast, 2021–2035
FIGURE 58: Hospital Outpatient Departments Market Forecast, 2021–2035
FIGURE 59: Ambulatory Surgery Centers Market Forecast, 2021–2035
FIGURE 60: Specialty Surgical Hospitals and Office-Based Facilities Market Forecast, 2021–2035
FIGURE 61: End-User Capital Procurement and Equipment Utilization Matrix
FIGURE 62: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 63: Procurement Channel Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 64: Direct Hospital and Health System Procurement Market Forecast, 2021–2035
FIGURE 65: Integrated Delivery Network Enterprise Contracts Market Forecast, 2021–2035
FIGURE 66: Group Purchasing Organization Contracts Market Forecast, 2021–2035
FIGURE 67: Distributor and Specialty Medical Equipment Sales Market Forecast, 2021–2035
FIGURE 68: ASC and Specialty Facility Procurement Market Forecast, 2021–2035
FIGURE 69: Leasing, Managed Equipment and Usage-Based Procurement Model Growth, 2021–2035
FIGURE 70: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 71: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: West Region Market Share and Leading Players, 2025
FIGURE 73: West Region Market Share Analysis by State, 2025
FIGURE 74: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 75: California Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 76: Washington Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 77: Arizona Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 78: Colorado Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 79: Oregon Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 80: Utah Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 81: Nevada Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 82: New Mexico Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 83: Idaho Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 84: Montana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 85: Wyoming Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 86: Alaska Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 87: Hawaii Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 88: Northeast Region Market Share and Leading Players, 2025
FIGURE 89: Northeast Region Market Share Analysis by State, 2025
FIGURE 90: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 91: New York Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 92: Massachusetts Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 93: New Jersey Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 94: Pennsylvania Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 95: Connecticut Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 96: Maine Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 97: Vermont Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 98: New Hampshire Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 99: Rhode Island Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 100: Delaware Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 101: South Region Market Share and Leading Players, 2025
FIGURE 102: South Region Market Share Analysis by State, 2025
FIGURE 103: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 104: Texas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 105: Florida Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 106: Georgia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 107: North Carolina Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 108: Tennessee Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 109: South Carolina Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 110: Alabama Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 111: Mississippi Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 112: Louisiana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 113: Arkansas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 114: Kentucky Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 115: Oklahoma Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 116: Virginia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 117: Maryland Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 118: West Virginia Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 119: Midwest Region Market Share and Leading Players, 2025
FIGURE 120: Midwest Region Market Share Analysis by State, 2025
FIGURE 121: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 122: Illinois Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 123: Ohio Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 124: Michigan Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 125: Minnesota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 126: Indiana Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 127: Wisconsin Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 128: Missouri Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 129: Iowa Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 130: Kansas Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 131: Nebraska Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 132: North Dakota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 133: South Dakota Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 134: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 135: Company Positioning Matrix
FIGURE 136: Key Player Equipment Portfolio Benchmarking
FIGURE 137: Surgical Robotics Competitive Benchmarking
FIGURE 138: Visualization and Integrated OR Competitive Benchmarking
FIGURE 139: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 140: Future Market Scenario Analysis, 2026–2035
FIGURE 141: Disruptive Technologies Impact Matrix
FIGURE 142: Next-Generation Surgical Robotics Adoption Roadmap
FIGURE 143: AI-Assisted Surgical Visualization Opportunity Map
FIGURE 144: Future of MIS in Ambulatory Surgery Centers
FIGURE 145: Capital Equipment Replacement Roadmap, 2026–2035
FIGURE 146: Emerging Business and Commercial Model Trends
FIGURE 147: Investment Prioritization Matrix
FIGURE 148: Strategic Growth Roadmap for MIS Equipment Manufacturers
FIGURE 149: Go-to-Market Strategy Framework
FIGURE 150: Product Positioning and Portfolio Expansion Framework
FIGURE 151: U.S. Regional Market Prioritization Framework
FIGURE 152: Hospital Value Analysis and Capital Equipment Commercialization Framework
FIGURE 153: Report Scope and Disclaimer Framework